[HTML][HTML] Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer

A Melhem-Bertrandt, M Chavez-MacGregor… - Journal of clinical …, 2011 - ncbi.nlm.nih.gov
A Melhem-Bertrandt, M Chavez-MacGregor, X Lei, EN Brown, RT Lee, F Meric-Bernstam
Journal of clinical oncology, 2011ncbi.nlm.nih.gov
Beta-Blocker Use Is Associated With Improved Relapse-Free Survival in Patients With Triple-Negative
Breast Cancer - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI
Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text Archive
Search in PMC Advanced Search User Guide Journal List J Clin Oncol PMC3139371 Other
Formats PDF (144K) Actions Cite Collections Share Permalink Copy RESOURCES Similar
articles Cited by other articles Links to NCBI Databases Journal List J Clin Oncol PMC3139371 …
Abstract
Purpose
To examine the association between beta-blocker (BB) intake, pathologic complete response (pCR) rates, and survival outcomes in patients with breast cancer treated with neoadjuvant chemotherapy.
ncbi.nlm.nih.gov